Replimune Group, Inc.: Form 10-Q for the period ended Sep 30, 2018
Filed with the SEC on Nov 14, 2018 and accepted by EDGAR at Nov 14, 2018, 16:04 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 6 months2018-04-01 to 2018-09-30 | $0 | us-gaap:Revenues |
| Research and development | 3 months2018-07-01 to 2018-09-30 | $5.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2018-04-01 to 2018-09-30 | $8.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-07-01 to 2018-09-30 | −$7.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-04-01 to 2018-09-30 | −$13.0m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2018-07-01 to 2018-09-30 | −$6.5m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-04-01 to 2018-09-30 | −$16.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-07-01 to 2018-09-30 | −$0.26 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 6 months2018-04-01 to 2018-09-30 | −$1.11 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 6 months2018-04-01 to 2018-09-30 | −$13.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-04-01 to 2018-09-30 | $119.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2018-09-30 | $23.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-09-30 | $151.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-09-30 | $153.8m | us-gaap:Assets |
| Current liabilities | At period end2018-09-30 | $3.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-09-30 | $3.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-09-30 | $150.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-18-068434. Last ingested by Listed: Nov 3, 2026, 23:32 ET. Listed shows no prices and gives no investment advice.